General Information of the Compound
| Compound ID |
CP0397743
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
1-[[5-chloro-4-[3-[4-(cyclopentanecarbonyl)piperazin-1-yl]-1,2,4-oxadiazol-5-yl]-2-fluorophenyl]methyl]azetidine-3-carboxylic acid
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C23H27ClFN5O4
|
||||||||||||||||||
| Molecular Weight |
491.951
|
||||||||||||||||||
| Canonical SMILES |
OC(=O)C1CN(Cc2cc(Cl)c(cc2F)-c2nc(no2)N2CCN(CC2)C(=O)C2CCCC2)C1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C23H27ClFN5O4/c24-18-9-15(11-28-12-16(13-28)22(32)33)19(25)10-17(18)20-26-23(27-34-20)30-7-5-29(6-8-30)21(31)14-3-1-2-4-14/h9-10,14,16H,1-8,11-13H2,(H,32,33)
Show/Hide
|
||||||||||||||||||
| InChIKey |
STZOUPXERQYDJW-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01688, Sphingosine 1-phosphate receptor 1
Protein ID: PT01838, Sphingosine 1-phosphate receptor 3